Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy
Sergey V. Brodsky, Nilesh S. Mhaskar, Sampath Thiruveedi, Rajnish Dhingra, Sharon C. Reuben, Edward Calomeni, Iouri Ivanov, Anjali Satoskar, Jessica Hemminger, Gyongyi Nadasdy, Lee Hebert, Brad Rovin, Tibor Nadasdy
Kidney Res Clin Pract. 2017;36(4):387-392.   Published online 2017 Dec 31     DOI: https://doi.org/10.23876/j.krcp.2017.36.4.387
Citations to this article as recorded by Crossref logo
Oral anticoagulant treatment and risk of kidney disease—a nationwide, population-based cohort study
Ane Emilie Friis Vestergaard, Simon Kok Jensen, Uffe Heide-Jørgensen, Kasper Adelborg, Henrik Birn, Juan-Jesus Carrero, Christian Fynbo Christiansen
Clinical Kidney Journal.2024;[Epub]     CrossRef
Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data
Qiuyu Xu, Gang Chen, Sanxi Ai, Ke Zheng, Bin Zhao, Xuemei Li
Cardiovascular Drugs and Therapy.2024;[Epub]     CrossRef
Respuesta a la carta al director referida a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»
Carmen Sánchez-Gonzalez, José A. Herrero Calvo
Nefrología.2023; 43(1): 150.     CrossRef
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
Marco Trevisan, Paul Hjemdahl, Catherine M. Clase, Ype de Jong, Marie Evans, Rino Bellocco, Edouard L. Fu, Juan Jesus Carrero
American Journal of Kidney Diseases.2023; 81(3): 307.     CrossRef
Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes
Shanshan Chen, Dehua Liao, Minghua Yang, Shengfeng Wang
Thrombosis Research.2023; 222: 20.     CrossRef
Reply to the letter to the editor regarding “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis, should we anticoagulate?”
Carmen Sánchez-Gonzalez, Jose A. Herrero Calvo
Nefrología (English Edition).2023; 43(1): 150.     CrossRef
The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas
Zhiwei Qiu, Xiaocong Pang, Qian Xiang, Yimin Cui
Journal of the American Society of Nephrology.2023; 34(11): 1793.     CrossRef
An Inconspicuous Offender: Apixaban-Induced Anticoagulant-Related Nephropathy
Dylan J Shaw, Stephanie Kaiser, Alexander Kong, Shivam Joshi
Cureus.2023;[Epub]     CrossRef
The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease
Jelena Simic, Miroslav Mihajlovic, Nevena Zec, Vladan Kovacevic, Milan Marinkovic, Nebojsa Mujovic, Tatjana Potpara
Expert Review of Cardiovascular Therapy.2023; 21(12): 937.     CrossRef
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
Hernando Trujillo, Justo Sandino, Teresa Cavero, Fernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M. Sevillano, Amir Shabaka, Gema Fernández-Juárez, Pablo Rodríguez Doyágüez, Rocío Gimena Muñoz, Leonardo Calle García, Virginia Cabello, José Manuel Muñoz
Kidney International Reports.2022; 7(4): 831.     CrossRef
Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use
Zhen-Ling Deng, Wen-Ling Yang, Xin-Yue Zhao, Zi-Yong Tang, Dan-Xia Zheng, Yue Wang
Renal Failure.2022; 44(1): 30.     CrossRef
Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?
Carmen Sánchez-González, Jose Antonio Herrero Calvo
Nefrología.2022; 42(6): 632.     CrossRef
Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases
Amayelle Rey, Valérie Gras, Julien Moragny, Gabriel Choukroun, Kamel Masmoudi, Sophie Liabeuf
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
Ajay Medipally, Min Xiao, Laura Biederman, Anjali A. Satoskar, Iouri Ivanov, Brad Rovin, Samir Parikh, Bryce A. Kerlin, Sergey V. Brodsky
Physiological Reports.2022;[Epub]     CrossRef
Challenging clinical scenarios for therapeutic anticoagulation: A practical approach
Kylee L. Martens, Simone E. Dekker, Megan Crowe, Thomas G. DeLoughery, Joseph J. Shatzel
Thrombosis Research.2022; 218: 72.     CrossRef
Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
Carmen Sánchez-González, Jose Antonio Herrero Calvo
Nefrología (English Edition).2022; 42(6): 633.     CrossRef
Anticoagulación oral en la enfermedad renal crónica con fibrilación auricular
Pablo Gómez-Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo
Nefrología.2021; 41(2): 137.     CrossRef
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
A. John Camm, Dan Atar
Thrombosis and Haemostasis.2021; 121(06): 716.     CrossRef
Acute kidney injury pathology and pathophysiology: a retrospective review
Joseph P Gaut, Helen Liapis
Clinical Kidney Journal.2021; 14(2): 526.     CrossRef
CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treated With Apixaban Versus Warfarin
James B. Wetmore, Heng Yan, Charles A. Herzog, Eric Weinhandl, Jorge L. Reyes, Nicholas S. Roetker
American Journal of Kidney Diseases.2021; 78(2): 180.     CrossRef
Role of glomerular filtration rate‐modifying drugs in the development of anticoagulant‐related nephropathy
Ajay K. Medipally, Min Xiao, Brad H. Rovin, Anjali A. Satoskar, Iouri Ivanov, Shahzeb Qaisar, Sergey V. Brodsky
Physiological Reports.2021;[Epub]     CrossRef
Management of Anticoagulant-Related Nephropathy: A Single Center Experience
Tanja Belčič Mikič, Nika Kojc, Maja Frelih, Andreja Aleš-Rigler, Željka Večerić-Haler
Journal of Clinical Medicine.2021; 10(4): 796.     CrossRef
Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
Patita Sitticharoenchai, Kullaya Takkavatakarn, Smonporn Boonyaratavej, Kearkiat Praditpornsilpa, Somchai Eiam‐Ong, Paweena Susantitaphong
Journal of the American Heart Association.2021;[Epub]     CrossRef
Oral anticoagulation in chronic kidney disease with atrial fibrillation
Pablo Gomez -Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo
Nefrología (English Edition).2021; 41(2): 137.     CrossRef
The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation
Thoranis Chantrarat, Sakolrat Hauythan
IJC Heart & Vasculature.2021; 35: 100844.     CrossRef
The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation
Ziv Harel, Eric McArthur, Nivethika Jeyakumar, Manish M. Sood, Amit X. Garg, Samuel A. Silver, Paul Dorian, Daniel Blum, William Beaubien-Souligny, Andrew T. Yan, Sunil V. Badve, Brendan Smyth, Min Jun, Racquel Jandoc, Abhijat Kitchlu, Ron Wald
Clinical Journal of the American Society of Nephrology.2021; 16(10): 1470.     CrossRef
The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients
Wei-Chieh Lee, Pai-Wei Lee, Po-Jui Wu, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Hsiu-Yu Fang, Shang-Hung Chang, Ping-Yen Liu, Mien-Cheng Chen
Thrombosis Journal.2021;[Epub]     CrossRef
A Case of Anticoagulant Related Nephropathy Caused by Dabigatran with a Clinical Presentation of Pulmonary Renal Syndrome
Tadashi Eguchi, Seiji Takenouchi, Naofumi Higuchi, Tomo Suzuki, Kanako Nagaoka, Keishin Sunagawa, Makito Yaegashi
Nihon Naika Gakkai Zasshi.2021; 110(5): 981.     CrossRef
Drug-Induced Glomerulonephritis
Frank B. Cortazar, Reza Zonozi
Nephrology Self-Assessment Program.2020; 19(2): 151.     CrossRef
Hematuria Is Associated with More Severe Acute Tubulointerstitial Nephritis
Raquel Esteras, Jonathan G. Fox, Colin C. Geddes, Bruce Mackinnon, Alberto Ortiz, Juan Antonio Moreno
Journal of Clinical Medicine.2020; 9(7): 2135.     CrossRef
Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function
Masaki Ikeda, Mari Tanaka, Saeko Shimoda, Hirona Saita, Seira Nishikawa, Hiroki Shimada, Keisuke Taniguchi, Koichiro Hagihara, Sachio Iwanari, Hiroya Takeoka
CEN Case Reports.2019; 8(4): 292.     CrossRef
Rivaroxaban-related acute kidney injury in a patient with IgA vasculitis
Yoshihiko Fujino, Chisato Takahashi, Kensuke Mitsumoto, Takashi Uzu
BMJ Case Reports.2019; 12(1): e227756.     CrossRef
Anticoagulation-Related Nephropathy: The Most Common Diagnosis You've Never Heard Of
Thomas Oliver, Liann Abu Salman, Brandon Ciaudelli, David A. Cohen
The American Journal of Medicine.2019; 132(8): e631.     CrossRef
Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
Christina DiMaria, Wael Hanna, Julie Murone, James Reichart
Drug and Therapeutics Bulletin.2019; 57(11): 173.     CrossRef
Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study
Mauro Molteni, Matteo Crippa, Annalisa Orenti, Hernan Polo Friz, Anna Menghini, Pierluigi Tramacere, Giuseppe Marano, Claudio Cimminiello, Patrizia Boracchi
Clinical Drug Investigation.2019; 39(4): 355.     CrossRef
Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
Christina DiMaria, Wael Hanna, Julie Murone, James Reichart
BMJ Case Reports.2019; 12(6): e230371.     CrossRef
Dabigatran Toxicity in Acute Kidney Injury: Hemodialysis and Idarucizumab Required
Lucy McBride, Julie Wang, Prahlad Ho, David Langsford
Kidney International Reports.2019; 4(3): 500.     CrossRef
Glomerular Hematuria: Cause or Consequence of Renal Inflammation?
Juan Antonio Moreno, Ángel Sevillano, Eduardo Gutiérrez, Melania Guerrero-Hue, Cristina Vázquez-Carballo, Claudia Yuste, Carmen Herencia, Cristina García-Caballero, Manuel Praga, Jesús Egido
International Journal of Molecular Sciences.2019; 20(9): 2205.     CrossRef
Anticoagulant-related nephropathy: a pathological note
Vincenzo L’Imperio, Alessia Guarnieri, Federico Pieruzzi, Renato Alberto Sinico, Fabio Pagni
Journal of Thrombosis and Thrombolysis.2018; 46(2): 260.     CrossRef
Anticoagulant-Related Nephropathy
Sergey Brodsky, John Eikelboom, Lee A. Hebert
Journal of the American Society of Nephrology.2018; 29(12): 2787.     CrossRef
Anticoagulant Related Nephropathy Induced by Dabigatran
Nazia Sharfuddin, Mahra Nourbakhsh, Alan Box, Hallgrimur Benediktsson, Daniel A. Muruve
Case Reports in Nephrology.2018; 2018: 1.     CrossRef
Apixaban
Reactions Weekly.2018; 1686(1): 51.     CrossRef